{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:41:07Z","timestamp":1787312467419,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T00:00:00Z","timestamp":1547596800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T00:00:00Z","timestamp":1547596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004167","name":"Medicines for Malaria Venture","doi-asserted-by":"publisher","award":["not available"],"award-info":[{"award-number":["not available"]}],"id":[{"id":"10.13039\/501100004167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["P18091"],"award-info":[{"award-number":["P18091"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13071-019-3296-z","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T09:02:43Z","timestamp":1547629363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Evaluation of the in vitro and in vivo inhibitory effect of thymoquinone on piroplasm parasites"],"prefix":"10.1186","volume":"12","author":[{"given":"Shimaa Abd El-Salam","family":"El-Sayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Abdo","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoaki","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,16]]},"reference":[{"key":"3296_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.vetpar.2006.01.035","volume":"31","author":"G Uilenberg","year":"2006","unstructured":"Uilenberg G. Babesia - a historical overview. Vet Parasitol. 2006;31:3\u201310.","journal-title":"Vet Parasitol."},{"key":"3296_CR2","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.parint.2017.07.004","volume":"66","author":"SAE El-Sayed","year":"2017","unstructured":"El-Sayed SAE, Rizk MA, Terkawi MA, Yokoyama N, Igarashi I. Molecular identification and antigenic characterization of Babesia divergens erythrocyte binding protein (BdEBP) as a potential vaccine candidate. Parasitol Int. 2017;66:721\u20136.","journal-title":"Parasitol Int."},{"key":"3296_CR3","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.apjtb.2015.09.001","volume":"5","author":"SAES El-Sayed","year":"2015","unstructured":"El-Sayed SAES, Rizk MA, Terkawi MA, Mousa A, El Said ESES, Elsayed G, et al. Cocktail of Theileria equi antigens for detecting infection in equines. Asian Pac J Trop Biomed. 2015;5:977\u201381.","journal-title":"Asian Pac J Trop Biomed."},{"key":"3296_CR4","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1128\/AAC.05488-11","volume":"56","author":"M AbouLaila","year":"2012","unstructured":"AbouLaila M, Munkhjargal T, Sivakumar T, Ueno A, Nakano Y, Yokoyama M, et al. Apicoplast targeting antibacterials inhibit the growth of Babesia parasites. Antimicrob Agents Chemother. 2012;56:3196\u2013206.","journal-title":"Antimicrob Agents Chemother."},{"key":"3296_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.vetpar.2009.09.049","volume":"167","author":"M AbouLaila","year":"2010","unstructured":"AbouLaila M, Nakamura K, Govind Y, Yokoyama N, Igarashi I. Evaluation of the in vitro growth inhibitory effect of epoxomicin on Babesia parasites. Vet Parasitol. 2010;167:19\u201327.","journal-title":"Vet Parasitol."},{"key":"3296_CR6","doi-asserted-by":"publisher","first-page":"e0125276","DOI":"10.1371\/journal.pone.0125276","volume":"27","author":"MA Rizk","year":"2015","unstructured":"Rizk MA, El-Sayed SA, Terkawi MA, Youssef MA, El Said El Sel S, Elsayed G, et al. Optimization of a fluorescence-based assay for large-scale drug screening against Babesia and Theileria parasites. PLoS One. 2015;27:e0125276.","journal-title":"PLoS One."},{"key":"3296_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.vetpar.2016.07.032","volume":"227","author":"MA Rizk","year":"2016","unstructured":"Rizk MA, El-Sayed SA, AbouLaila M, Tuvshintulga B, Yokoyama N, Igarashi I. Large-scale drug screening against Babesia divergens parasite using a fluorescence-based high-throughput screening assay. Vet Parasitol. 2016;227:93\u20137.","journal-title":"Vet Parasitol."},{"key":"3296_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.exppara.2017.06.003","volume":"179","author":"MA Rizk","year":"2017","unstructured":"Rizk MA, El-Sayed SAE, AbouLaila M, Yokoyama N, Igarashi I. Evaluation of the inhibitory effect of N-acetyl-L-cysteine on Babesia and Theileria parasites. Exp Parasitol. 2017;179:43\u20138.","journal-title":"Exp Parasitol."},{"key":"3296_CR9","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.2174\/092986712799828355","volume":"19","author":"J Mosqueda","year":"2012","unstructured":"Mosqueda J, Olvera-Ramirez A, Aguilar-Tipacamu G, Canto GJ. Current advances in detection and treatment of babesiosis. Curr Med Chem. 2012;19:1504\u201318.","journal-title":"Curr Med Chem."},{"key":"3296_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0378-8741(01)00216-1","volume":"76","author":"MS Al-Ghamdi","year":"2001","unstructured":"Al-Ghamdi MS. The anti-inflammatory, analgesic and antipyretic activity of Nigella sativa. J Ethnopharmacol. 2001;76:45\u20138.","journal-title":"J Ethnopharmacol."},{"key":"3296_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-8741(01)00310-5","volume":"79","author":"MR Mahmoud","year":"2002","unstructured":"Mahmoud MR, El-Abhar HS, Salh S. The effect of Nigella sativa oil against the liver damage induced by Schistosoma mansoni infection in mice. J Ethnopharmacol. 2002;79:1\u201311.","journal-title":"J Ethnopharmacol."},{"key":"3296_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/1099-1573(200008)14:5<323::AID-PTR621>3.0.CO;2-Q","volume":"14","author":"M Burits","year":"2000","unstructured":"Burits M, Bucar F. Antioxidant activity of Nigella sativa essential oil. Phytother Res. 2000;14:323\u20138.","journal-title":"Phytother Res."},{"key":"3296_CR13","first-page":"270","volume":"43","author":"R Fujisaki","year":"2012","unstructured":"Fujisaki R, Kamei K, Yamamura M, Nishiya H, Inouye S, Takahashi M, et al. In vitro and in vivo anti-plasmodial activity of essential oils, including hinokitiol. Southeast Asian J Trop Med Public Health. 2012;43:270.","journal-title":"Southeast Asian J Trop Med Public Health."},{"key":"3296_CR14","doi-asserted-by":"publisher","first-page":"e75356","DOI":"10.1371\/journal.pone.0075356","volume":"8","author":"CC Woo","year":"2013","unstructured":"Woo CC, Hsu A, Kumar AP, Sethi G, Tan KHB. Thymoquinone inhibits tumor growth and induces apoptosis in a breast cancer xenograft mouse model: the role of p38 MAPK and ROS. PLoS One. 2013;8:e75356.","journal-title":"PLoS One."},{"key":"3296_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10495-009-0421-z","volume":"15","author":"N El-Najjar","year":"2010","unstructured":"El-Najjar N, Chatila M, Moukadem H, Vuorela H, Ocker M, Gandesiri M, et al. Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling. Apoptosis. 2010;15:183\u201395.","journal-title":"Apoptosis."},{"key":"3296_CR16","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1139\/y97-169","volume":"75","author":"OA Badary","year":"1997","unstructured":"Badary OA, Nagi MN, Al-Shabanah OA, Al-Sawaf HA, Al-Sohaibani MO, Al-Bekairi AM. Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity. Can J Physiol Pharmacol. 1997;75:1356\u201361.","journal-title":"Can J Physiol Pharmacol."},{"key":"3296_CR17","first-page":"193","volume":"17","author":"OA Al-Shabanah","year":"1998","unstructured":"Al-Shabanah OA, Badary OA, Nagi MN, Al-Gharably NM, Al-Rikabi AC, Al-Bekairi AM. Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity. J Exp Clin Cancer Res. 1998;17:193\u20138.","journal-title":"J Exp Clin Cancer Res."},{"key":"3296_CR18","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1128\/AAC.48.1.236-241.2004","volume":"48","author":"S Bork","year":"2004","unstructured":"Bork S, Yokoyama N, Ikehara Y, Kumar S, Sugimoto C, Igarashi I. Growth-inhibitory effect of heparin on Babesia parasites. Antimicrob Agents Chemother. 2004;48:236\u201341.","journal-title":"Antimicrob Agents Chemother."},{"key":"3296_CR19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00436-013-3654-2","volume":"113","author":"AA Salama","year":"2014","unstructured":"Salama AA, AbouLaila M, Terkawi MA, Mousa A, El-Sify A, Allaam M, et al. Inhibitory effect of allicin on the growth of Babesia and Theileria equi parasites. Parasitol Res. 2014;113:275\u201383.","journal-title":"Parasitol Res."},{"key":"3296_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1017\/S0031182003003895","volume":"127","author":"S Bork","year":"2003","unstructured":"Bork S, Yokoyama N, Matsuo T, Claveria FG, Fujisaki K, Igarashi I. Clotrimazole, ketoconazole, and clodinafoppropargyl inhibit the in vitro growth of Babesia bigemina and Babesia bovis (Phylum Apicomplexa). Parasitology. 2003;127:311\u20135.","journal-title":"Parasitology."},{"key":"3296_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13052-5","volume":"7","author":"MA Rizk","year":"2017","unstructured":"Rizk MA, El-Sayed SAES, AbouLaila M, Eltaysh R, Yokoyama N, Igarashi I. Performance and consistency of a fluorescence-based high-throughput screening assay for use in Babesia drug screening in mice. Sci Rep. 2017;7:12774.","journal-title":"Sci Rep."},{"key":"3296_CR22","first-page":"25","volume":"20","author":"A Al-Ali","year":"2008","unstructured":"Al-Ali A, Alkhawajah AA, Randhawa MA, Shaikh NA. Oral and intraperitoneal LD50 of thymoquinone, an active principle of Nigella sativa, in mice and rats. J Ayub Med Coll Abbottabad. 2008;20:25\u20137.","journal-title":"J Ayub Med Coll Abbottabad."},{"key":"3296_CR23","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1080\/01635581.2010.509832","volume":"62","author":"S Banerjee","year":"2010","unstructured":"Banerjee S, Padhye S, Azmi A, Wang Z, Philip PA, Kucuk O, et al. Review on molecular and therapeutic potential of thymoquinone in cancer. Nutr Cancer. 2010;62:938\u201346.","journal-title":"Nutr Cancer."},{"key":"3296_CR24","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3389\/fphar.2017.00656","volume":"8","author":"SN Goyal","year":"2017","unstructured":"Goyal SN, Prajapati CP, Gore PR, Patil CR, Mahajan UB, Sharma C, et al. Therapeutic potential and pharmaceutical development of thymoquinone: a multitargeted molecule of natural origin. Front Pharmacol. 2017;8:656.","journal-title":"Front Pharmacol."},{"key":"3296_CR25","doi-asserted-by":"publisher","first-page":"e1005763","DOI":"10.1371\/journal.ppat.1005763","volume":"12","author":"WC Van Voorhis","year":"2016","unstructured":"Van Voorhis WC, Adams JH, Adelfio R, Ahyong V, Akabas MH, Alano P, et al. Open source drug discovery with the malaria box compound collection for neglected diseases and beyond. PLoS Pathog. 2016;12:e1005763.","journal-title":"PLoS Pathog."},{"key":"3296_CR26","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1128\/AAC.01614-15","volume":"60","author":"B Tuvshintulga","year":"2016","unstructured":"Tuvshintulga B, AbouLaila M, Davaasuren B, Ishiyama A, Sivakumar T, Yokoyama N, et al. Clofazimine inhibits the growth of Babesia and Theileria parasites in vitro and in vivo. Antimicrob Agents Chemother. 2016;60:2739\u201346.","journal-title":"Antimicrob Agents Chemother."},{"key":"3296_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vetpar.2008.07.023","volume":"157","author":"A Matsuu","year":"2008","unstructured":"Matsuu A, Yamasaki M, Xuan X, Ikadai H, Hikasa Y. In vitro evaluation of the growth inhibitory activities of 15 drugs against Babesia gibsoni (Aomori strain). Vet Parasitol. 2008;157:1\u20138.","journal-title":"Vet Parasitol."},{"key":"3296_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vetpar.2012.08.022","volume":"191","author":"AA Salama","year":"2013","unstructured":"Salama AA, AbouLaila M, Mousa AA, Nayel MA, El-Sify A, Terkawi MA, et al. Inhibitory effect of fusidic acid on the growth of Babesia and Theileria equi parasites. Vet Parasitol. 2013;191:1\u201310.","journal-title":"Vet Parasitol."},{"key":"3296_CR29","first-page":"600","volume":"50","author":"PV Turner","year":"2011","unstructured":"Turner PV, Brabb T, Pekow C, Vasbinder MA. Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci. 2011;50:600\u201313.","journal-title":"J Am Assoc Lab Anim Sci."},{"key":"3296_CR30","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1136\/vr.134.4.100","volume":"134","author":"SE Wolfensohn","year":"1994","unstructured":"Wolfensohn SE, Lloyd MH. Aleutian disease in laboratory ferrets. Vet Rec. 1994;134:100.","journal-title":"Vet Rec."},{"key":"3296_CR31","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1017\/S0031182009991594","volume":"137","author":"M AbouLaila","year":"2010","unstructured":"AbouLaila M, Yokoyama N, Igarashi I. Inhibitory effects of (\u2212)- epigallocatechin-3-gallate from green tea on the growth of Babesia parasites. Parasitology. 2010;137:785\u201391.","journal-title":"Parasitology."},{"key":"3296_CR32","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.parint.2010.02.006","volume":"59","author":"M AbouLaila","year":"2010","unstructured":"AbouLaila M, Sivakumar T, Yokoyama N, Igarashi I. Inhibitory effect of terpene nerolidol on the growth of Babesia parasites. Parasitol Int. 2010;59:278\u201382.","journal-title":"Parasitol Int."},{"key":"3296_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1128\/AAC.41.1.91","volume":"41","author":"SE Marley","year":"1997","unstructured":"Marley SE, Eberhard ML, Steurer FJ, Ellis WL, McGreevy PB, Ruebush TK 2nd. Evaluation of selected antiprotozoal drugs in the Babesia microti hamster model. Antimicrob Agents Chemother. 1997;41:91\u20134.","journal-title":"Antimicrob Agents Chemother."},{"key":"3296_CR34","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.2147\/IDR.S159519","volume":"11","author":"MA Rizk","year":"2018","unstructured":"Rizk MA, AbouLaila M, El-Sayed SAE, Guswanto A, Yokoyama N, Igarashi I. Inhibitory effects of fluoroquinolone antibiotics on Babesia divergens and Babesia microti, blood parasites of veterinary and zoonotic importance. Infect Drug Resist. 2018;11:1605\u201315.","journal-title":"Infect Drug Resist."}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-019-3296-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-019-3296-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-019-3296-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T09:17:29Z","timestamp":1589534249000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-019-3296-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,16]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3296"],"URL":"https:\/\/doi.org\/10.1186\/s13071-019-3296-z","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,16]]},"assertion":[{"value":"11 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental protocols in this study were approved by the Animal Care and Use Committee, Obihiro University of Agriculture and Veterinary Medicine (approval no. 27\u201365).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"37"}}